1. Home
  2. PWP vs ARDX Comparison

PWP vs ARDX Comparison

Compare PWP & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$18.16

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.99

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PWP
ARDX
Founded
2006
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
PWP
ARDX
Price
$18.16
$5.99
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$23.50
$15.14
AVG Volume (30 Days)
693.0K
2.8M
Earning Date
05-01-2026
04-30-2026
Dividend Yield
1.60%
N/A
EPS Growth
138.52
N/A
EPS
0.47
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
$31.87
$37.75
Revenue Next Year
$17.04
$34.24
P/E Ratio
$37.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.44
$3.50
52 Week High
$25.93
$8.40

Technical Indicators

Market Signals
Indicator
PWP
ARDX
Relative Strength Index (RSI) 52.78 50.98
Support Level $17.05 $5.49
Resistance Level $18.97 $6.23
Average True Range (ATR) 0.74 0.26
MACD 0.25 0.06
Stochastic Oscillator 91.21 94.71

Price Performance

Historical Comparison
PWP
ARDX

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: